lobbying_activities: 2787298

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2787298	00f2f6a6-08c9-49ff-9bb2-1db451516e52	Q1	RAMPY NORTHRUP LLC	401103289	ASTRAZENECA PHARMACEUTICALS LP	2022	first_quarter	PHA	Provide legislative and regulatory advice related to vaccine development, drug pricing, the 340B Drug Pricing Program, PDUFA Reauthorization, and clinical trial diversity; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; H.R.6000, Cures 2.0 Act; FY2022 Budget Reconciliation (H.R.5376); H.R.5585, Advanced Research Project Agency-Health Act; H.R.5030/S.2706, DIVERSE Trials Act.	HOUSE OF REPRESENTATIVES	60000		0	0	2022-04-19T16:40:55-04:00